Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Optical coherence tomography angiography in evaluating the response of ocular surface squamous neoplasia to topical
Hamidreza Ghanbari1, Ahmad Masoumi2, Mahsan Samadi1
1Department of Ophthalmology, Farabi Eye Hospital, School of Medicine, Tehran University of Medical Sciences, Qazvin Sq, Tehran, Iran.
Purpose:
To evaluate the changes in OCTA parameters in patients with ocular surface squamous neoplasia (OSSN) during treatment with topical interferon α-2b (IFN-α2b).
Methods:
Thirty-five patients who were diagnosed with OSSN were included in this study. All the patients underwent comprehensive ophthalmic examination, including slit lamp examination, and the size of the lesion was recorded by slit lamp photography. All the patients received topical IFN-α2b (1 million IU/ml, 4 times a day). OCTA images of the ocular surface were obtained at three time points: before initiation of treatment, during treatment, and at tumor resolution. Vessel density (VD), Vessel length density (VLD), and Vessel diameter index (VDI) were measured in superficial and deep vascular flows.
Results:
The mean age of the patients was 60.4 ± 15.7 years. The mean tumor area was 20.7 ± 23.6 mm2 at presentation, which decreased to 15.1 ± 21.8 mm2 during treatment. Mean time to resolution was 112.4 ± 62.1 days. The mean superficial VD decreased significantly in the course of treatment (36.3%± 6.8% at presentation, 33.1%±7.5% during treatment, and 30.5%±4.9% after tumor resolution, P < 0.05). Mean superficial VDI also decreased significantly in the course of treatment (1.87 ± 0.16 at presentation, 1.83 ± 0.13 during treatment, and 1.74 ± 0.1 after tumor resolution, P < 0.05). No significant change was observed in deep VD, deep VDI, superficial and deep VLD.
Conclusion:
OCTA can be used successfully to evaluate vascular changes in OSSN during medical treatment. Superficial VD and superficial VDI might be useful to evaluate treatment response to topical treatment.
Insights
Topical interferon α-2b (IFN-α2b) effectively treats ocular surface squamous neoplasia (OSSN). Optical coherence tomography angiography (OCTA) reveals significant decreases in superficial vessel density and diameter, indicating treatment response.
Area of Science:
- Ophthalmology
- Oncology
- Medical Imaging
Background:
- Ocular surface squamous neoplasia (OSSN) is a pre-malignant or malignant epithelial tumor.
- Topical interferon α-2b (IFN-α2b) is a common treatment for OSSN.
- Evaluating treatment efficacy requires monitoring tumor vascularity.
Purpose of the Study:
- To assess changes in Optical Coherence Tomography Angiography (OCTA) parameters during topical IFN-α2b treatment for OSSN.
- To determine if OCTA can effectively monitor treatment response in OSSN patients.
Main Methods:
- Thirty-five OSSN patients received topical IFN-α2b.
- Ophthalmic examinations and slit lamp photography were performed.
- OCTA imaging captured ocular surface vasculature at baseline, during treatment, and post-resolution.
- Superficial and deep vascular density (VD), vessel length density (VLD), and vessel diameter index (VDI) were quantified.
Main Results:
- Mean tumor area decreased from 20.7 mm² to 15.1 mm² during treatment.
- Superficial VD significantly decreased from 36.3% to 30.5% (P<0.05).
- Superficial VDI significantly decreased from 1.87 to 1.74 (P<0.05).
- No significant changes were noted in deep vascular parameters or VLD.
Conclusions:
- OCTA is a valuable tool for evaluating vascular changes in OSSN during medical treatment.
- Decreases in superficial VD and VDI may serve as indicators of successful response to topical IFN-α2b therapy.
More Related Videos
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
07:08Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Tumor Immunotherapy
Angle Closure Glaucoma: Treatment